HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
James L Maggs Selected Research
James L Maggs Research Topics
Disease
10
Hypersensitivity (Allergy)
01/2021 - 09/2002
3
Drug-Related Side Effects and Adverse Reactions
11/2012 - 11/2003
2
Allergic Contact Dermatitis
06/2009 - 02/2007
2
Agranulocytosis (Granulocytopenia)
11/2003 - 10/2003
1
Dehydration (Water Stress)
01/2017
1
Chemical and Drug Induced Liver Injury
01/2015
1
Malaria
01/2011
1
Mitochondrial Diseases (Mitochondrial Disease)
01/2011
1
Contact Dermatitis (Eczema, Contact)
03/2009
1
Carcinoma (Carcinomatosis)
03/2007
1
Cardiomyopathies (Cardiomyopathy)
10/2003
1
Myocarditis (Carditis)
10/2003
Drug/Important Bio-Agent (IBA)
4
Proteins (Proteins, Gene)
FDA Link
08/2014 - 06/2009
3
Carbamazepine (Tegretol)
FDA Link
Generic
01/2021 - 11/2012
3
Sulfamethoxazole
FDA Link
Generic
01/2010 - 09/2002
3
Tuberculin (PPD)
IBA
06/2009 - 02/2007
3
4-phenylenediamine (p-phenylenediamine)
FDA Link
06/2009 - 02/2007
2
Anticonvulsants (Antiepileptic Drugs)
IBA
01/2017 - 11/2012
1
Dapsone
FDA Link
12/2017
1
Oxides
IBA
01/2017
1
Isoniazid (Ftivazide)
FDA Link
Generic
01/2015
1
Protein S
IBA
08/2014
1
Albumins
IBA
08/2014
1
Glucuronides
IBA
08/2014
1
Diclofenac (SR 38)
FDA Link
Generic
08/2014
1
abacavir (Ziagen)
FDA Link
04/2014
1
HLA-B57 antigen
IBA
04/2014
1
Nucleosides
IBA
04/2014
1
Reverse Transcriptase Inhibitors
IBA
04/2014
1
Penicillins (Penicillin)
FDA Link
09/2011
1
Haptens
IBA
09/2011
1
Artesunate
IBA
01/2011
1
artemisinin (artemisinine)
IBA
01/2011
1
Carbon
IBA
01/2011
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2011
1
Cytochrome P-450 CYP2C9
IBA
12/2008
1
Hydroxylamine (Hydroxylamine Hydrochloride)
IBA
12/2008
1
Iron
IBA
03/2007
1
Hair Dyes
IBA
02/2007
1
Amodiaquine (Camoquin)
FDA Link
11/2003
1
amodiaquine quinoneimine
IBA
11/2003
1
Antimalarials (Antimalarial Agents)
IBA
11/2003
1
4-aminoquinoline
IBA
11/2003
1
Clozapine (Clozaril)
FDA Link
Generic
10/2003
1
Antigens
IBA
09/2002
Therapy/Procedure
1
Therapeutics
01/2017